Article
The Synchrony Dual-Optic Accommodative IOL (Visiogen Inc.) has a promisingfuture, according to Gerd Auffarth, MD, but there is room for improvementin the IOL calculation.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.